Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Biomarker (BASKET).php on line 2
Biomarker (BASKET)
LE WE PMID CA
Biomarker (BASKET)368Biomarker (allg)

alpha1 microglobulin

Alzheimer s disease

Angiogenesis

Bioelectrical impedance

Bioinformatics

Biomarker (BASKET)

CNS (Stroke BASKET)

Cystatin C

Data base (Medicine Biology Pharmacology)

Drug development

Epigenetics

Fetuin A

Gro alpha

Immune histochemistry

Interleukin18

Kidney (Failure acute)

Kidney (Neoplasm)

Kidney injury molecule1

Laboratory medicine

Mass spectrometry

Meprin

Neoplasia (Circulating tumor cells)

NGAL

Proteomics

Statistics and trial design

Toxicology (BASKET)

2000  
1
Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.
[10817547] Arthritis Rheum 43(5): 953-68 (2000)
2006  
2
Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.
[17047111] Gut 55(11): 1650-60 (2006)
2009  
3
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
[19468990] World J Gastroenterol 15(20): 2433-40 (2009)
2006  
4
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
[16773685] World J Gastroenterol 12(23): 3682-94 (2006)
2006  
5
Sampling and analytical strategies for biomarker discovery using mass spectrometry.
[16774124] Biotechniques 40(6): 799-805 (2006)
2008  
6
Validation of analytic methods for biomarkers used in drug development.
[18829475] Clin Cancer Res 14(19): 5967-76 (2008)
2009  
7
Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma.
[19402074] Cancer 115(10 Suppl): 2346-54 (2009)
2010  
8
The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification.
[20007861] Clin Chem 56(2): 212-22 (2010)
2010  
9
Integration of proteomic-based tools for improved biomarkers of myocardial injury.
[20022985] Clin Chem 56(2): 194-201 (2010)
2010  
10
Proteomics research to discover markers: what can we learn from Netflix?
[20040622] Clin Chem 56(2): 172-6 (2010)
2010  
11
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment.
[19926776] Clin Chem 56(1): 21-33 (2010)
2005  
12
Developmental mechanisms facilitating the evolution of bills and quills.
[16313392] J Anat 207(5): 563-73 (2005)
2010  
13
DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancers.
[20222788] Future Oncol 6(3): 333-6 (2010)
2008  
14
Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.
[18573345] Methods 46(1): 33-8 (2008)
2007  
15
Proteomics for biomarker discovery in acute kidney injury.
[18061846] Semin Nephrol 27(6): 637-51 (2007)
2010  
16
Biomarker detection in the integration of multiple multi-class genomic studies.
[19965884] Bioinformatics 26(3): 333-40 (2010)
2010  
17
Chromatin conformation signatures: ideal human disease biomarkers?
[20701449] Biomark Med 4(4): 611-29 (2010)
2010  
18
Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice.
[20701445] Biomark Med 4(4): 583-6 (2010)
2007  
19
Microdissected tissue: an underestimated source for biomarker discovery?
[20477395] Biomark Med 1(2): 217-9 (2007)
2009  
20
Risks in biomarker analysis resulting in unfit data use in clinical drug development.
[20477501] Biomark Med 3(2): 103-7 (2009)
2011  
21
2010  
22
Proteomic approaches to cancer biomarkers.
[19931265] Gastroenterology 138(1): 46-51.e1 (2010)
2011  
23
Biomarkers in development of psychotropic drugs.
[21842620] Dialogues Clin Neurosci 13(2): 225-34 (2011)
2008  
24
The proteogenomic path towards biomarker discovery.
[18764911] Pediatr Transplant 12(7): 737-47 (2008)
2010  
25
Systems biology and the discovery of diagnostic biomarkers.
[20534905] Dis Markers 28(4): 199-207 (2010)
2009  
26
Perspective: proteomic approach to detect biomarkers of human growth hormone.
[19501004] Growth Horm IGF Res 19(4): 399-407 (2009)
2011  
27
Bioinformatic-driven search for metabolic biomarkers in disease.
[21884622] J Clin Bioinforma 1(1): 2 (2011)
2010  
28
Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory.
[21137030] Proteomics Clin Appl 4(12): 892-903 (2010)
2008  
29
Novel technologies for the discovery and quantitation of biomarkers of toxicity.
[18237837] Toxicology 245(3): 167-74 (2008)
2009  
30
Biomarker discovery in neurodegenerative diseases: a proteomic approach.
[18938247] Neurobiol Dis 35(2): 157-64 (2009)
2009  
31
From differentiating metabolites to biomarkers.
[19277615] Anal Bioanal Chem 394(3): 663-70 (2009)
2010  
32
Introduction of new tools for chemical biology research on microbial metabolites.
[20530900] Biosci Biotechnol Biochem 74(6): 1135-40 (2010)
2009  
33
Targeted proteomics for validation of biomarkers in clinical samples.
[19109305] Brief Funct Genomic Proteomic 8(2): 126-35 (2009)
2005  
34
Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
[15975261] Brief Funct Genomic Proteomic 4(1): 16-26 (2005)
2005  
35
Proteomics approaches to biomarker detection.
[15975266] Brief Funct Genomic Proteomic 4(1): 69-75 (2005)
2010  
36
Statistical methods for assessment of added usefulness of new biomarkers.
[20716010] Clin Chem Lab Med 48(12): 1703-11 (2010)
2011  
37
Biomarkers of neurodegenerative diseases.
[21320030] Clin Chem Lab Med 49(3): 343-4 (2011)
2011  
38
Biomarkers in Alzheimer's disease.
[21303300] Clin Chem Lab Med 49(5): 773-8 (2011)
2011  
39
Circulating tumor cells as emerging tumor biomarkers in breast cancer.
[21801030] Clin Chem Lab Med 49(10): 1579-90 (2011)
2010  
40
An appraisal of statistical procedures used in derivation of reference intervals.
[21062226] Clin Chem Lab Med 48(11): 1537-51 (2010)
2008  
41
Clinical biomarkers of angiogenesis inhibition.
[18414993] Cancer Metastasis Rev 27(3): 415-34 (2008)
2010  
42
Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer.
[20614087] Analyst 135(10): 2496-511 (2010)
2011  
43
Plasmatic markers in hemorrhagic stroke.
[21776296] J Med Life 4(2): 148-50 (2011)
2010  
44
Immunohistochemistry as an important tool in biomarkers detection and clinical practice.
[20212918] Biomark Insights 5(-): 9-20 (2010)
2007  
45
Biomarker discovery in animal health and disease: the application of post-genomic technologies.
[19662203] Biomark Insights 2(-): 185-96 (2007)
2007  
46
Methodology and applications of disease biomarker identification in human serum.
[19662190] Biomark Insights 2(-): 21-43 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Biomarker (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Biomarker (BASKET).php on line 92